BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37724205)

  • 1. Cardiac Structure and Function in Patients With Obesity and Non-alcoholic Fatty Liver Disease.
    Asatullina Z; Sineglazova AV
    Cureus; 2023 Aug; 15(8):e43711. PubMed ID: 37724205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease.
    Sonaglioni A; Cerini F; Cerrone A; Argiento L; Nicolosi GL; Rigamonti E; Lombardo M; Rumi MG; Viganò M
    Intern Emerg Med; 2022 Aug; 17(5):1425-1438. PubMed ID: 35302179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant Association between Subclinical Left Cardiac Dysfunction and Liver Stiffness in Metabolic Syndrome Patients with Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease.
    Apostu A; Malita D; Arnautu SF; Tomescu MC; Gaiță D; Popescu A; Mare R; Gidea R; Arnautu DA
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837528
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.
    Parvanescu T; Vitel A; Sporea I; Mare R; Buz B; Bordejevic DA; Tomescu MC; Arnautu SF; Morariu VI; Citu IM
    Diabetes Metab Syndr Obes; 2021; 14():1535-1545. PubMed ID: 33859484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension.
    Catena C; Brosolo G; Da Porto A; Donnini D; Bulfone L; Vacca A; Soardo G; Sechi LA
    Front Cardiovasc Med; 2022; 9():1030968. PubMed ID: 36312275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial.
    Attaran F; Emami S; Sohrabi M; Malek M; Ajdarkosh H; Khoonsari M; Ismail-Beigi F; Khamseh ME
    BMC Gastroenterol; 2023 Sep; 23(1):327. PubMed ID: 37742004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study.
    VanWagner LB; Wilcox JE; Ning H; Lewis CE; Carr JJ; Rinella ME; Shah SJ; Lima JAC; Lloyd-Jones DM
    J Am Heart Assoc; 2020 Feb; 9(4):e014279. PubMed ID: 32067588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography.
    Chang W; Wang Y; Sun L; Yu D; Li Y; Li G
    Echocardiography; 2019 Jul; 36(7):1290-1297. PubMed ID: 31206765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.
    Bonapace S; Perseghin G; Molon G; Canali G; Bertolini L; Zoppini G; Barbieri E; Targher G
    Diabetes Care; 2012 Feb; 35(2):389-95. PubMed ID: 22210573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction.
    Chung GE; Lee JH; Lee H; Kim MK; Yim JY; Choi SY; Kim YJ; Yoon JH; Kim D
    Atherosclerosis; 2018 May; 272():137-144. PubMed ID: 29604480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
    Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
    Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and Management of Cirrhotic Cardiomyopathy.
    Kaur H; Premkumar M
    J Clin Exp Hepatol; 2022; 12(1):186-199. PubMed ID: 35068798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Prognostic Value of Non-Alcoholic Fatty Liver Disease in Patients Hospitalized With Decompensated Chronic Heart Failure.
    Misan IA; Arisheva OS; Garmash IV; Cabello FR; Kobalava ZD
    Kardiologiia; 2023 Dec; 63(12):72-76. PubMed ID: 38156493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease.
    Sert A; Aypar E; Pirgon O; Yilmaz H; Odabas D; Tolu I
    Am J Cardiol; 2013 Aug; 112(3):436-43. PubMed ID: 23642511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Cao YT; Xiang LL; Qi F; Zhang YJ; Chen Y; Zhou XQ
    EClinicalMedicine; 2022 Sep; 51():101547. PubMed ID: 35844772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status.
    Jiang W; Liu Z; Liu S; Du T
    Front Endocrinol (Lausanne); 2023; 14():1183075. PubMed ID: 37941902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Non- alcoholic Fatty Liver Disease and Left Ventricular Diastolic Dysfunction in Patients of Type 2 Diabetes.
    Saluja M; Kumar K; Swami YK; Meena SR; Goyal S
    J Assoc Physicians India; 2019 Aug; 67(8):20-24. PubMed ID: 31562711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.